As one of the most important medical research hubs in the country the National Institutes of Health (NIH) has been leading the fight against COVID-19 since the earliest days of the pandemic. With a fast-paced roll-out of funding and programs, streamlining operations at the NIH was imperative to avoid duplication to both save budgets and optimize research and results. In doing so the NIH would be able to help deliver necessities – whether that was PPE or targeted data for clinical trials – at the right moment to the right place.
Andrew Kelly, Budget Officer at the National Center for Advancing Translational Sciences (NCATS) at the NIH, where he also serves as the chief of the Center’s Financial Management Branch, explained the situation the NIH found themselves in in early April 2020 at recent event hosted by Qlik. “When COVID came along, all of a sudden everyone started standing up research programs,” shared Kelly. “We realized very quickly that there was lots of redundancy, lots of people doing a lot of the same things or searching for the same types of resources.”
Read more.
